1 |
Kahn, B.B., Flier, J.S. Obesity and insulin resistance. J. Clin. Invest. 106: 473-481, 2000.
DOI
|
2 |
Kim, J.A., Wei, Y., Sowers, J.R. Role of mitochondrial dysfunction in insulin resistance. Circ. Res. 102: 401-414, 2008.
DOI
|
3 |
Chen, X.H., Zhao, Y.P., Xue, M., Ji, C.B., Gao, C.L., Zhu, J.G., et al. TNF-alpha induces mitochondrial dysfunction in 3T3-L1 adipocytes. Mol. Cell. Endocrinol. 328: 63-69, 2010.
DOI
|
4 |
Anusree, S.S., Nisha, V.M., Priyanka, A., Raghu, K.G. Insulin resistance by TNF-alpha is associated with mitochondrial dysfunction in 3T3-L1 adipocytes and is ameliorated by punicic acid, a PPARgamma agonist. Mol. Cell. Endocrinol. 413: 120-128, 2015.
DOI
|
5 |
Cawthorn, W.P., Sethi, J.K. TNF-alpha and adipocyte biology. FEBS Lett 582: 117-131, 2008.
DOI
|
6 |
Daniele, G., Guardado Mendoza, R., Winnier, D., Fiorentino, T.V., Pengou, Z., Cornell, J., et al. The inflammatory status score including IL-6, TNF-alpha, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol. 51: 123-131, 2014.
DOI
|
7 |
Yeo, J., Kang, Y.M., Cho, S.I., Jung, M.H. Effects of a multi-herbal extract on type 2 diabetes. Chin Med. 6: 10, 2011.
DOI
|
8 |
Suneetha, W.J., Krishnakantha, T.P. Cardamom extract as inhibitor of human platelet aggregation. Phytother Res. 19: 437-440, 2005.
DOI
|
9 |
Roberts, L.D., Virtue, S., Vidal-Puig, A., Nicholls, A.W., Griffin, J.L. Metabolic phenotyping of a model of adipocyte differentiation. Physiol. Genomics. 39: 109-119, 2009.
DOI
|
10 |
Im, S.S., Kwon, S.K., Kang, S.Y., Kim, T.H., Kim, H.I., Hur, M.W., et al. Regulation of GLUT4 gene expression by SREBP-1c in adipocytes. Biochem. J. 399: 131-139, 2006.
DOI
|
11 |
Jitrapakdee, S., Slawik, M., Medina-Gomez, G., Campbell, M., Wallace, J.C., Sethi, J.K., et al. The peroxisome proliferator-activated receptor-gamma regulates murine pyruvate carboxylase gene expression in vivo and in vitro. J. Biol. Chem. 280: 27466-27476, 2005.
DOI
|
12 |
Wheatcroft, S.B., Kearney, M.T., Shah, A.M., Ezzat, V.A., Miell, J.R., Modo, M., et al. IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes 56: 285-294, 2007.
DOI
|
13 |
Ahn, J., Lee, H., Kim, S., Ha, T. Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt/beta-catenin signaling. Am. J. Physiol., Cell Physiol. 298: C1510-1516, 2010.
DOI
|
14 |
Qatanani, M., Lazar, M.A. Mechanisms of obesity- associated insulin resistance: many choices on the menu. Genes Dev. 21: 1443-1455, 2007.
DOI
|
15 |
Brannmark, C., Nyman, E., Fagerholm, S., Bergenholm, L., Ekstrand, E.M., Cedersund, G., et al. Insulin signaling in type 2 diabetes: experimental and modeling analyses reveal mechanisms of insulin resistance in human adipocytes. J. Biol. Chem. 288: 9867-9880, 2013.
DOI
|
16 |
Chen, L., Chen, R., Wang, H., Liang, F. Mechanisms Linking Inflammation to Insulin Resistance. Int J Endocrinol. 2015: 508409, 2015.
|
17 |
Lee, O.H., Lee, H.H., Kim, J.H., Lee, B.Y. Effect of ginsenosides Rg3 and Re on glucose transport in mature 3T3-L1 adipocytes. Phytother Res. 25: 768-773, 2011.
DOI
|
18 |
Anusree, S.S., Nisha, V.M., Priyanka, A., Raghu, K.G. Insulin resistance by TNF-alpha is associated with mitochondrial dysfunction in 3T3-L1 adipocytes and is ameliorated by punicic acid, a PPARgamma agonist. Mol. Cell. Endocrinol., 413: 120-128. 2015.
DOI
|
19 |
Hotamisligil, G.S. Inflammation and metabolic disorders. Nature 444: 860-867, 2006.
DOI
|
20 |
Maury, E., Brichard, S.M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol. Cell. Endocrinol. 314: 1-16, 2010.
DOI
|
21 |
Kahn, S.E., Hull, R.L., Utzschneider, K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840-846, 2006.
DOI
|
22 |
Serrano-Marco, L., Barroso, E., El Kochairi, I., Palomer, X., Michalik, L., Wahli, W., et al. The peroxisome proliferator- activated receptor (PPAR) beta/delta agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells. Diabetologia. 55: 743-751, 2012.
DOI
|
23 |
Gao, Z., Hwang, D., Bataille, F., Lefevre, M., York, D., Quon, M.J., et al. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. The J. Biol. Chem. 277: 48115-48121, 2002.
DOI
|
24 |
Kanda, H., Tateya, S., Tamori, Y., Kotani, K., Hiasa, K., Kitazawa, R., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116: 1494-1505, 2006.
DOI
|
25 |
Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112: 1821-1830, 2003.
DOI
|
26 |
Aguirre, V., Werner, E.D., Giraud, J., Lee, Y.H., Shoelson, S.E., White, M.F. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 277: 1531-1537, 2002.
DOI
|
27 |
Zhande, R., Mitchell, J.J., Wu, J., Sun, X.J. Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1. Mol. Cell. Endocrinol. 22: 1016-1026, 2002.
|